- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05098730
Strategy Training and Pets to Promote Stroke Survivor's Cognitive Performance and Community Participation
August 6, 2024 updated by: Naor Demeter, University of Haifa
The study will administer an intervention called strategy training to adult stroke survivors living in the community who do and do not have pets, and will examine the role of a pet in promoting cognitive performance and community participation outcomes.
Study Overview
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Naor Domotor, PhD
- Phone Number: 4123836617
- Email: NAD129@pitt.edu
Study Contact Backup
- Name: Elizabeth Skidmore, PhD
- Phone Number: 4123836617
- Email: skidmore@pitt.edu
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15219
- University of Pittsburgh
-
Contact:
- Minmei Shih, PhD, OTR/L
- Phone Number: 412-383-6752
- Email: mis235@pitt.edu
-
Contact:
- Elizabeth R Skidmore, PhD, OTR/L
- Phone Number: (412) 383-6617
- Email: skidmore@pitt.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Stroke survivors with pets
Inclusion Criteria:
- Primary diagnosis of acute stroke
- At least 3 months after the stroke onset
- Living in a community residence with a pet
- Cognitive impairment as indicated by an Executive Interview score of 3 or higher
- Participation restrictions as indicated by an Activity Card Sort (<80% of pre-stroke activities)
- Willing to participate in a 6-week program with 2 intervention sessions per week at home
Exclusion Criteria:
- Dementia as indicated by Montreal Cognitive Assessment score of 18 or lower
- Severe aphasia as indicated by the Boston Diagnostic Aphasia Examination Severity Score of 0 or 1
- Self-report of a central nervous system disorder other than stroke
- Recent drug or alcohol addiction/abuse within 3 months prior to the Mini-Neuropsychiatric Interview
- Severe mental illness as indicated by the PRIME-MD
- Prior exposure to strategy training
- Currently participate in rehabilitation therapy programs
Stroke survivors without pets
Inclusion Criteria:
- Primary diagnosis of acute stroke
- At least 3 months after the stroke onset
- Living in a community residence
- Cognitive impairment as indicated by an Executive Interview score of 3 or higher
- Participation restrictions as indicated by an Activity Card Sort (<80% of pre-stroke activities)
- Willing to participate in a 6-week program with 2 intervention sessions per week at home
Exclusion Criteria:
- Dementia as indicated by Montreal Cognitive Assessment score of 18 or lower
- Severe aphasia as indicated by the Boston Diagnostic Aphasia Examination Severity Score of 0 or 1
- Self-report of a central nervous system disorder other than stroke
- Recent drug or alcohol addiction/abuse within 3 months prior to the Mini-Neuropsychiatric Interview
- Severe mental illness as indicated by the PRIME-MD
- Prior exposure to strategy training
- Currently participate in rehabilitation therapy programs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Stroke survivors with pets
Stroke survivors with pets will receive strategy training for 10-15 sessions, 45 minutes each session, delivered by a trained occupational therapist in the home.
|
Strategy training is comprised of participant-selected activity based goals, self evaluation, global problem solving strategies, and therapist-delivered guided training.
The strategy training therapist will guide participants using prompting questions, as well as work sheets that facilitate learning and aid the participants in implementing the process.
|
|
Active Comparator: Stroke survivors without pets
Stroke survivors without pets will receive strategy training for 10-15 sessions, 45 minutes each session, delivered by a trained occupational therapist in the home.
|
Strategy training is comprised of participant-selected activity based goals, self evaluation, global problem solving strategies, and therapist-delivered guided training.
The strategy training therapist will guide participants using prompting questions, as well as work sheets that facilitate learning and aid the participants in implementing the process.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean engagement score as measured by the Pittsburgh Rehabilitation Participation Scale
Time Frame: Baseline to 6 weeks
|
The scale is a valid and reliable criterion referenced measure that assesses engagement in rehabilitation therapy sessions.
Each session is scored by the occupational therapist, 1 (no participation, refusal) to 6 (excellent participation).
Scores are averaged across the 10-15 intervention sessions to generate the mean engagement score.
|
Baseline to 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in attention as measured by the Color Trail Test 1
Time Frame: Baseline to 3 months
|
This measure assesses perceptual tracking, sustained attention and grapho-motor skills.
It is a pencil and paper, timed test.
Completion time in seconds for each task is recorded, with a lower score representing better function.
Change in attention will be calculated by subtracting the time to do the task at baseline from the time to do the task at 3 months.
|
Baseline to 3 months
|
|
Change in executive function as measured by the Color Trail Test 2
Time Frame: Baseline to 3 months
|
This measure assesses divided attention and sequencing skills, which are executive function performance.
It is a pencil and paper, timed test of effortful executive processing abilities that assesses the ability to alternate between two colors.
Completion time in seconds for each task is recorded, with a lower score representing better function.
Change in executive function will be calculated by subtracting the time to do the task at baseline from the time to do the task at 3 months.
|
Baseline to 3 months
|
|
Change in community participation as measure by Community Participation Indicators score
Time Frame: Baseline to 3 months
|
This participant reported questionnaire will measure the frequency of community participation over a 7 days period.
Each item is measured on a 5-point Likert scale, with 1=no participation in that activity and 5=7 days of participation in that activity.
A total of 20 items are summed to yield a total score.
Change in community participation will be calculated by subtracting baseline total score from the 3 month total score.
|
Baseline to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Naor Domotor, PhD, University of Pittsburgh
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
October 1, 2024
Primary Completion (Estimated)
December 31, 2025
Study Completion (Estimated)
June 30, 2026
Study Registration Dates
First Submitted
October 15, 2021
First Submitted That Met QC Criteria
October 15, 2021
First Posted (Actual)
October 28, 2021
Study Record Updates
Last Update Posted (Actual)
August 9, 2024
Last Update Submitted That Met QC Criteria
August 6, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY21080031
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Strategy Training
-
Ibn Haldun UniversityCompletedAnxiety | Depressive Symptoms | Anxiety Disorders and Symptoms | Emotional Dysregulation | SadnessTurkey (Türkiye)
-
MGH Institute of Health ProfessionsLSVT GlobalCompleted
-
University of PittsburghEunice Kennedy Shriver National Institute of Child Health and Human Development...Terminated
-
University of PittsburghCompletedStroke | Adherence, Patient | Strategy TrainingUnited States
-
Taipei Medical UniversityActive, not recruitingStroke | Cognitive ImpairmentTaiwan
-
Taipei Medical UniversityActive, not recruitingStroke | Cognitive Impairment | Acquired Brain InjuryTaiwan
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingAcute Coronary SyndromeFrance
-
Rutgers, The State University of New JerseyNational Institute on Aging (NIA)RecruitingAlzheimer's Disease (AD) | Healthy AgingUnited States
-
Taipei Medical UniversityRecruiting
-
Washington University School of MedicineCompleted